Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHL1500633	鲁比前列酮胶囊	lubiprostone	Capsule	Chemical Drugs(3.1)	New Drug Application	2015-05-12	苏州朗科生物技术有限公司	Suzhou Lanxite Biotechnology Co Ltd	Certificate Issued	2016-08-04	view
CXHL1500632	鲁比前列酮	lubiprostone	Active ingredient	Chemical Drugs(3.1)	New Drug Application	2015-05-12	苏州朗科生物技术有限公司	Suzhou Lanxite Biotechnology Co Ltd	Certificate Issued	2016-08-04	view
CXHL1500634	鲁比前列酮胶囊	lubiprostone	Capsule	Chemical Drugs(3.1)	New Drug Application	2015-05-12	苏州朗科生物技术有限公司	Suzhou Lanxite Biotechnology Co Ltd	Certificate Issued	2016-08-04	view